Caredx Inc sell Biotechhunter
Summary
This prediction ended on 07.09.20 with a price of €26.64. With a performance of -6.10%, the SELL prediction by Biotechhunter was trending in the right direction. Biotechhunter has 50% into this predictionCareDx is a publicly traded biotechnology company that specializes in providing innovative transplant solutions for patients suffering from various diseases. The company has developed a range of diagnostic solutions that help doctors monitor the health of organ transplant recipients, including tests that can detect early signs of organ rejection. CareDx has a strong track record of developing cutting-edge medical technologies and working with leading healthcare providers to improve patient outcomes. As a publicly-listed company, CareDx has a diverse shareholder base and is subject to the scrutiny of regulatory bodies, providing transparency and accountability to investors.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Caredx Inc | 5.069% | 5.069% | -8.049% | 93.067% |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % | 44,61 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % | 70,74 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % | 48,21 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % | 54,25 % |
Comments by Biotechhunter for this prediction
In the thread Caredx Inc diskutieren
In the thread Trading Caredx Inc


